Payette Healthcare of Cascadia: Medication Safety Failures - ID
Inspectors visited the facility on September 8, 2025, and found Resident 53 sitting in her recliner watching television. On the table in front of her were two versions of oxymetazoline hydrochloride nasal spray, including a store-brand Equate version, and a fluticasone propionate steroid nasal spray. When an inspector asked how often she used the sprays, Resident 53 said it depended on which medication was going to work.
None of them had been ordered by her physician.
Resident 53 has chronic obstructive pulmonary disease, a progressive lung disease that causes increasing breathlessness. The inspection report does not say where the medications came from, how long they had been on her table, or whether any staff member had previously noticed them.
Two days later, on September 10, the facility's Director of Nursing reviewed Resident 53's physician orders and confirmed there was no order for either the oxymetazoline or the fluticasone. The review happened because inspectors asked for it.
The second case involved Resident 28, who was admitted to the facility with a complete intestinal obstruction and has a colostomy, a surgical opening through the abdominal wall that bypasses the rectum. Managing bowel function is a central part of that resident's care.
The physician orders for Resident 28 showed four laxative prescriptions, all dated September 1, 2023. Two of them were for bisacodyl rectal suppository, 10 milligrams, one listed by its generic name and one listed as Dulcolax, the brand name for the same drug. Two were for magnesium hydroxide oral suspension, one listed by its generic name and one listed as Milk of Magnesia, again the same drug under a different name. Both pairs of orders carried identical dosing instructions.
The orders had sat in the chart for two years.
On September 12, the Director of Nursing told inspectors that Dulcolax and bisacodyl are the same medication, that Milk of Magnesia and magnesium hydroxide are the same medication, and that Resident 28 had duplicate orders for both in error. The inspection report does not indicate whether staff had ever administered both versions of either drug simultaneously, or whether anyone had flagged the duplication before inspectors raised it.
The deficiency was cited at the minimal harm level, meaning inspectors determined no actual harm had occurred, though they noted the potential for adverse reactions if either resident received medications inappropriately. For Resident 28, receiving double doses of a stimulant suppository or an oral laxative could cause serious complications, particularly given a digestive system already altered by surgery. For Resident 53, oxymetazoline nasal sprays carry warnings against extended use, and steroid nasal sprays like fluticasone interact with other medications in ways a physician would need to account for in a patient with a serious lung condition.
The inspection covered seven residents whose medications were reviewed. Two had problems.
What the report captures, without elaborating on it, is a quiet version of a common failure: medications that exist outside the formal order system, and orders that exist inside the system but contradict each other, and neither situation caught until someone from outside the facility came in and looked. Resident 53 was not hiding the nasal sprays. They were sitting on her table in plain view. She answered the inspector's question directly. She had her own method for deciding which to use.
Nobody on staff, as far as the inspection record shows, had asked her the same question.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Payette Healthcare of Cascadia from 2025-09-12 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: This article is based on inspection data downloaded directly from the Centers for Medicare & Medicaid Services (CMS) via Medicare.gov. CMS releases inspection reports in bulk; we publish the findings as documented by state surveyors in the official Form CMS-2567 Statement of Deficiencies.
Plan of correction: The CMS report we receive does not include the facility's plan of correction. Facilities submit plans of correction separately to state survey agencies and those responses may not be reflected in CMS data at the time of publication. The absence of a plan of correction in our data does not mean one was not filed. Readers who want information about corrective steps taken are encouraged to contact the facility directly or their state survey agency.
Corrections may have occurred: Inspection reports reflect conditions observed on the date of the survey. Facilities may have implemented corrections, staffing changes, additional training, or other remediation since the report was issued. We report what CMS provides and encourage readers to seek current information from the facility.
Editorial process: Inspection findings are extracted from CMS source documents and synthesized using AI, reviewed for factual accuracy against the original report by our editorial team.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: September 20, 2026 · Our methodology
Payette Healthcare of Cascadia in Payette, ID was cited for violations during a health inspection on September 12, 2025.
Inspectors visited the facility on September 8, 2025, and found Resident 53 sitting in her recliner watching television.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.